(Q48385788)

11 February 2018

title

Anxiolytic-like action of neurokinin substance P administered systemically or into the nucleus basalis magnocellularis region. (English)

1 reference

11 February 2018

0 references

4

1 reference

11 February 2018

author name string

Hasenöhrl RU

1

1 reference

11 February 2018

Jentjens O

2

1 reference

11 February 2018

De Souza Silva MA

3

1 reference

11 February 2018

Huston JP

5

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 August 1998

1 reference

11 February 2018

European Journal of Pharmacology

published in

1 reference

11 February 2018

volume

354

1 reference

11 February 2018

issue

2-3

1 reference

11 February 2018

page(s)

123-133

1 reference

11 February 2018

Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Substance P in CSF of patients with chronic pain syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Peptides and the blood-brain barrier: lipophilicity as a predictor of permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Preprotachykinin gene expression in the forebrain: regulation by dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

The cardiovascular startle response: anxiety and the benzodiazepine receptor complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Link between emotional memory and anxiety states: a study by principal component analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Absence of amnestic effect of an anxiolytic 5-HT3 antagonist (BRL 46470A) injected into basolateral amygdala, as opposed to diazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Aversive and appetitive properties of anxiogenic and anxiolytic agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Tachykinin receptor types: Classification and membrane signalling mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Anxiolytic-like effect of combined extracts of Zingiber officinale and Ginkgo biloba in the elevated plus-maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

The role of neuropeptides in learning: focus on the neurokinin substance P.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Sequence-specific effects of neurokinin substance P on memory, reinforcement, and brain dopamine activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Endogenous benzodiazepine modulation of memory processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Self-administration of neurokinin substance P into the ventromedial caudate-putamen in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Substance P in the ventral pallidum: projection from the ventral striatum, and electrophysiological and behavioral consequences of pallidal substance P

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Neurotransmitter functions of mammalian tachykinins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Behavioral and adaptive status in an experimental model of Alzheimer's disease in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Different behavioral profiles of the non-peptide substance P (NK-1) antagonists CP-96,345 and RP 67580

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

High density of benzodiazepine binding sites in the substantia innominata of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Effects of chronic substance P treatment and intracranial fetal grafts on learning after hippocampal kainic acid lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

A role for the mesolimbic dopamine system in the reinforcing properties of diazepam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Behavioural depressant and antinociceptive properties of substance P in the mouse: Possible implication of brain monoamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Facilitation of conditioned inhibitory avoidance by post-trial peripheral injection of substance P.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Localization in the amygdala of the amnestic action of diazepam on emotional memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

The anxiolytic-like activity of GR159897, a non-peptide NK2 receptor antagonist, in rodent and primate models of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Diazepam effects on the exploratory behaviour of rats in an elevated runway: evidence for biphasic effects of benzodiazepines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Modulation of inwardly rectifying channels by substance P in cholinergic neurones from rat brain in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Use of the selective benzodiazepine-1 (BZ-1) ligand [3H]2-oxo-quazepam (SCH 15-725) to localize BZ-1 receptors in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

The substance P (NK1) receptor antagonist (±)-CP-96,345 causes sedation and motor impairment in Swiss albino mice in the black-and-white box behavioral paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Different behavioral profiles of the non-peptide substance P (NK1) antagonists CP-96,345 and RP 67580 in Swiss albino mice in the black-and-white box.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

Disturbances of neophobia and taste-aversion learning after bilateral kainate microlesions in the rat pallidum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900441-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(98)00441-5

1 reference

11 February 2018

PubMed ID

9754912

1 reference

11 February 2018